Rituximab for chronic fatigue syndrome (ME/CFS) trial
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests if rituximab, a drug that affects the immune system, can help people with ME/CFS. You'll receive the drug in the hospital and be monitored for safety and improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with ME/CFS by a doctor using Canadian criteria.
- Your fatigue must be moderate to severe (score 4 or higher on a specific scale).
- You must be between 18 and 65 years old.
- You must be able to stay in the hospital overnight for each dose.
- You cannot have other medical conditions that cause fatigue, like severe depression or immune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests rituximab (an immune system medicine) to see if it improves myasthenia gravis (MG) symptoms and function. It’s for adults with confirmed MG and moderate-to-severe impact on daily activities despite current care.
This trial tests a health-psychology–based rehabilitation program delivered in a group setting for people with chronic fatigue syndrome (ME/CFS). It may help by teaching strategies to cope with symptoms and improving daily functioning through structured group support.
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
This study looks at how post-exertional malaise (PEM) affects people with ME/CFS. It aims to understand the condition better and find new ways to help.
This trial studies how people with ME/CFS respond to an exercise test. It may help researchers understand what kind of exercise response is typical and how it relates to symptoms.
This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.
Hear when a new Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.